Inclusion Criteria:  Participant must be greater than or equal to (≥)18 years of age; Participant must be enrolled in Study AG348-C-008.  Exclusion Criteria:  - Participant is enrolled in an Agios-sponsored clinical study involving treatment with a pyruvate kinase activator.